Peter Kovar

6.4k total citations
39 papers, 993 citations indexed

About

Peter Kovar is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Peter Kovar has authored 39 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Peter Kovar's work include Cancer-related Molecular Pathways (14 papers), DNA Repair Mechanisms (11 papers) and Cancer therapeutics and mechanisms (9 papers). Peter Kovar is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), DNA Repair Mechanisms (11 papers) and Cancer therapeutics and mechanisms (9 papers). Peter Kovar collaborates with scholars based in United States, United Kingdom and Norway. Peter Kovar's co-authors include Saul H. Rosenberg, Zehan Chen, Hing L. Sham, Nan‐Horng Lin, Thomas J. Sowin, Haiying Zhang, Zhi‐Fu Tao, Stephen K. Tahir, Eric F. Johnson and Gaoquan Li and has published in prestigious journals such as Science, Blood and Endocrinology.

In The Last Decade

Peter Kovar

39 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Kovar United States	19	612	379	261	142	78	39	993
Daniel D. Holsworth United States	15	592 1.0×	187 0.5×	133 0.5×	72 0.5×	77 1.0×	36	865
Carl Crysler United States	19	304 0.5×	325 0.9×	145 0.6×	53 0.4×	31 0.4×	37	782
Takashi Hayama Japan	14	366 0.6×	335 0.9×	179 0.7×	70 0.5×	51 0.7×	42	849
Benjamin Greedy United Kingdom	13	641 1.0×	348 0.9×	417 1.6×	44 0.3×	18 0.2×	14	1.3k
Yasuhiro Imaeda Japan	17	828 1.4×	161 0.4×	284 1.1×	60 0.4×	65 0.8×	30	1.1k
Bernd Riedl Germany	20	684 1.1×	482 1.3×	148 0.6×	61 0.4×	67 0.9×	42	1.2k
Eric T. Sun United States	16	596 1.0×	264 0.7×	265 1.0×	94 0.7×	22 0.3×	20	1.0k
Rob Howes United Kingdom	13	578 0.9×	420 1.1×	118 0.5×	154 1.1×	10 0.1×	14	1.1k
Matthew G. Bursavich United States	17	504 0.8×	379 1.0×	106 0.4×	149 1.0×	12 0.2×	29	904
Chu‐Biao Xue United States	22	577 0.9×	320 0.8×	197 0.8×	49 0.3×	28 0.4×	52	1.0k

Countries citing papers authored by Peter Kovar

Since Specialization

Citations

This map shows the geographic impact of Peter Kovar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kovar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kovar more than expected).

Fields of papers citing papers by Peter Kovar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kovar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kovar. The network helps show where Peter Kovar may publish in the future.

Co-authorship network of co-authors of Peter Kovar

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kovar. A scholar is included among the top collaborators of Peter Kovar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kovar. Peter Kovar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phillips, Darren C., Cory Alvey, Justin P. Ingram, et al.. (2024). Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2. Blood. 144(Supplement 1). 4966–4966. 1 indexed citations

Güllich, Arne, et al.. (2016). Sport activities differentiating match-play improvement in elite youth footballers – a 2-year longitudinal study. Journal of Sports Sciences. 35(3). 207–215. 34 indexed citations

Akritopoulou‐Zanze, Irini, Alan F. Gasiecki, Douglas Kalvin, et al.. (2011). Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions. Bioorganic & Medicinal Chemistry Letters. 21(5). 1480–1483. 34 indexed citations

Fidanze, Steve, Scott Erickson, Gary T. Wang, et al.. (2010). Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 20(8). 2452–2455. 50 indexed citations

Hasvold, Lisa, Le Wang, Zhan Xiao, et al.. (2008). Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(7). 2311–2315. 10 indexed citations

Tong, Yunsong, Zhi‐Fu Tao, Jennifer J. Bouska, et al.. (2007). Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability. Bioorganic & Medicinal Chemistry Letters. 17(20). 5665–5670. 5 indexed citations

Tao, Zhi‐Fu, Zehan Chen, Peter Kovar, et al.. (2007). Macrocyclic ureas as potent and selective Chk1 inhibitors: An improved synthesis, kinome profiling, structure–activity relationships, and preliminary pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 17(23). 6593–6601. 13 indexed citations

Li, Gaoquan, Zhi‐Fu Tao, Yunsong Tong, et al.. (2007). Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(23). 6499–6504. 9 indexed citations

Tao, Zhi‐Fu, Gaoquan Li, Yunsong Tong, et al.. (2007). Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4308–4315. 22 indexed citations

10.

Tong, Yunsong, Akiyo Claiborne, Kent D. Stewart, et al.. (2007). Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors. Bioorganic & Medicinal Chemistry. 15(7). 2759–2767. 33 indexed citations

11.

Li, Gaoquan, Lisa Hasvold, Zhi‐Fu Tao, et al.. (2006). Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(8). 2293–2298. 29 indexed citations

12.

Chen, Zehan, Zhan Xiao, Wen‐Zhen Gu, et al.. (2006). Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics. International Journal of Cancer. 119(12). 2784–2794. 103 indexed citations

13.

Comess, Kenneth M., Chang Park, Zehan Chen, et al.. (2006). Kinase Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS): Application to DNA Damage Checkpoint Kinase Chk1. SLAS DISCOVERY. 11(7). 755–764. 24 indexed citations

14.

Gwaltney, Stephen L., Qun Li, Laura Gehrke, et al.. (2001). Novel sulfonate Derivatives: potent antimitotic agents. Bioorganic & Medicinal Chemistry Letters. 11(13). 1671–1673. 18 indexed citations

15.

Wang, Shen, Stephen A. Fakhoury, Kenneth J. Henry, et al.. (1999). Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacements. Bioorganic & Medicinal Chemistry Letters. 9(5). 703–708. 7 indexed citations

16.

Augeri, David J., Douglas Kalvin, Daniel A. Dickman, et al.. (1999). Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 9(8). 1069–1074. 28 indexed citations

17.

Rosenberg, Saul H., Kenneth P. Spina, Zhu Yao, et al.. (1993). Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3-[[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517). Journal of Medicinal Chemistry. 36(4). 460–467. 36 indexed citations

18.

Wessale, Jerry L., Samuel V. Calzadilla, Steven A. Boyd, et al.. (1993). Cardiovascular Effects and Hemodynamic Mechanism of Action of the Novel, Nonpeptidic Renin Inhibitor A-74273 in Dogs. Journal of Cardiovascular Pharmacology. 22(4). 644–652. 8 indexed citations

19.

Wessale, Jerry L., Hollis D. Kleinert, Samuel V. Calzadilla, Peter Kovar, & Saul H. Rosenberg. (1993). Effects of Renin Inhibitor A-72517 on Hemodynamics and Cardiac Function in Sodium-Depleted Dogs. American Journal of Hypertension. 6(6_Pt_1). 514–521. 9 indexed citations

20.

Scoccia, Bert, Peter Kovar, & Robert Benveniste. (1991). Gonadal and Adrenal Effects on Hepatic Epidermal Growth Factor Receptor Expression in a Murine Model*. Endocrinology. 129(6). 3240–3246. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact